Medical Science Liaison

Alzheon, Inc. | Preserving Future Memories

Location: US-based (heavy travel component to North American clinical trial sites)

Reports to: Chief Medical Officer



Alzheon is a clinical-stage biopharmaceutical company committed to developing innovative medicines by directly addressing the underlying pathology of devastating illnesses, such as Alzheimer’s disease (AD) and other neurodegenerative disorders characterized by accumulation of toxic, misfolded proteins. Our lead Alzheimer’s clinical candidate, ALZ-801, is  a unique oral, amyloid anti-oligomer agent, currently undergoing a Phase 3 study for the treatment of Early AD patients with two copies of the ε4 allele of the apolipoprotein E gene (APOE4/4). Building on eight years of research in amyloid oligomer biology, and an evidence foundation of 2000 patients treated with the active ingredient of ALZ-801, Alzheon scientists have found a better way to block the harmful effects of brain proteins called soluble amyloid oligomers, now recognized as the key triggers of cognitive worsening seen in early AD.

Our experienced and passionate drug development team is focused on applying precision medicine, cutting-edge disease biomarkers, brain imaging and unique biologic insights to advance therapies with the greatest impact for patients. We are seeking individuals with an entrepreneurial spirit to join our team and help make the first oral Alzheimer’s disease-modifying therapy a reality for patients and their families, in a few short years.

Position Overview

Alzheon is seeking to expand its team with a highly motivated Medical Science Liaison (MSL) to spearhead its engagement of key medical experts and clinical trial sites in North America. The MSL will drive education of Alzheon’s program for what’s set to be the world’s first safe and efficacious disease modifying oral treatment for Alzheimer’s disease, ALZ-801. The incumbent will be accountable for educating the community and key stakeholders on the advantages of ALZ-801 for patients as the landscape of Alzheimer’s treatments are evolving on a near daily basis, and sharing insights back with internal team members as appropriate. This role will be fundamental to helping bring to market a world-changing therapy to help slow or even prevent that cause of Alzheimer’s disease in a highly target population of patients known to respond to our drug.

Job Description

  • Serve as the main liaison between investigators & their study staff and Alzheon clinical or CMC teams
  • Engage clinical trial sites for Alzheon’s APOLLOE4 Phase 3 study to provide scientific & clinical education on AD
  • Address site questions regarding the protocol or data on Alzheon’s investigational therapy, ALZ-801
  • Help sites in outreach and recruitment strategies, customized to their geographic region
  • Build & maintain a network of KOLs, scientific collaborators & advisors
  • Support the communication strategy for ALZ-801, including publications, conferences & press releases
  • Engage & manage vendors to build educational campaigns on early AD diagnosis, value of APOE4 genotyping & role of biomarkers in drug approvals
  • Manage and support vendors to promote awareness and visibility on social networks or print media

Required Skills

  • Excellent presentation skills
  • Deep understanding of Alzheimer’s disease and treatment landscape
  • Knowledgeable about precision medicine and genetic testing practices
  • Strong communication skills, both written and verbal
  • Strong interpersonal skills, excellent teamwork, organizational, interpersonal, conflict resolution and problem-solving skills
  • Must be proactive, self-disciplined and able to work independently
  • Ability to build and maintain relationships with clinical trial sites, investigators, and KOLs
  • Ability to travel as needed

Experience and Qualifications

  • MD, PhD, PharmD, or equivalent
  • Minimum of 5 years’ experience in medical affairs
  • Minimum of 5 years’ experience in CNS/Alzheimer’s disease

Job Location

US-based (heavy travel component to North American clinical trial sites)

Position Type


Alzheon is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law.

  • Employment type